NIKKEI 225
27,574.86-572.65(-2.03%)HANG SENG
27,892.84-338.20(-1.20%)CRUDE OIL
65.37-0.71(-1.07%)
Sanofi (SNYNF)
| Previous close | 98.75 |
| Open | 105.92 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 98.75 - 98.75 |
| 52-week range | 88.75 - 108.61 |
| Volume | 182 |
| Avg. volume | 11,948 |
| Market cap | 129.112B |
| Beta (5Y monthly) | 0.40 |
| PE ratio (TTM) | 8.40 |
| EPS (TTM) | 11.75 |
| Earnings date | N/A |
| Forward dividend & yield | 3.86 (3.91%) |
| Ex-dividend date | 05 May 2021 |
| 1y target est | N/A |
- Motley Fool
Is Sanofi a Good Buy in 2021?
The French-based pharmaceutical company Sanofi (NASDAQ: SNY) has been flying under the radar over the past few years as companies like AbbVie, Bristol Myers Squibb, and Merck have dominated the space through the tremendous success of their drugs. Sanofi was actually a creation of several different companies, including Aventis, Synthélabo, Hoechst, Rhône-Poulenc Rorer, and several others. Through mergers and acquisitions (M&A) we got the Sanofi we know today.
- Yahoo Finance Video
COVID-19 booster shot is likely and ‘it’s okay’: Doctor
Dr. Andre Campbell, Professor of Surgery of UCSF & ICU Physician and Trauma Surgeon at Zuckerberg San Francisco General Hospital, joins Yahoo Finance’s Kristin Myers and Alexis Christoforous to discuss the latest on the coronavirus pandemic.
- Yahoo Finance Video
COVID-19 is not at the point yet where we can have mass gatherings: Doctor
Dr. Stella Safo, NYC-based HIV primary care physician, joins Yahoo Finance’s Kristin Myers and Alexis Christoforous to discuss the latest on the coronavirus pandemic.
